Journal of ethnopharmacology

PloS one

International journal of molecular sciences

inflammatory bowel diseases

clinical microbiology reviews

family medicine

Journal of gastroenterology and hepatology

klinicheskaia laboratornaia diagnostika

clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association

clinical and experimental immunology

international dental journal

experimental and therapeutic medicine

Gut

Neurology(R) neuroimmunology & neuroinflammation

modern rheumatology

journal of biomechanical engineering

biochemistry and cell biology = biochimie et biologie cellulaire

folia medica cracoviensia

Journal of medical ultrasonics (2001)

[1] The epidemiology of inflammatory bowel disease: East meets West.

[2] Training Residents in Maternal Depression Care to Improve Child Health: A CERA Study.

[3] Measuring Three-dimensional Knee Kinematics Using a Femoral Clamp: Accuracy, Repeatability and Reproducibility in Gait.

[4] Successful development of methodology for detection of hapten-specific contact hypersensitivity (CHS) memory in swine.

[5] The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.

[6] How does the method change what we measure? Comparing virtual reality and text-based surveys for the assessment of moral decisions in traffic dilemmas.

[7] Inter-individual genomic heterogeneity within European population isolates.

[8] Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.

[9] Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology.

[10] Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.

[11] Comparison of the efficacy of available statistical methods for prediction of the hospitalizations number: proof of concept and validation based on the analysis of Polish National Health Fund data in the years 2009-2017.

[12] Diet in treatment of Inflammatory Bowel Diseases.

[13] Pathobionts Associated with Inflammatory Bowel Disease.

[14] Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease.

[15] Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis

[16] nrf-2 expression in ulcerative colitis lesions and its correlation with antioxidant enzyme levels and tissue injury

[17] Вікові особливості стану печінки у хворих на хронічні запальні захворювання кишечника за даними стеатометрії та зсувнохвильової еластометрії

[18] central role of the gut epithelial barrier in pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics

[19] markers of hypoxia correlate with histologic and endoscopic severity of colitis in inflammatory bowel disease

[20] vedolizumab in patients with inflammatory bowel diseases of in real clinical practice

[21] intestinal epithelium in inflammatory bowel disease

[22] rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach

[23] qualidade de vida de pacientes portadores de doença inflamatória intestinal calidad de vida de pacientes portadores de enfermedad inflamatoria intestinal quality of life of patients with inflammatory bowel disease

[24] state of igg4-positive plasma cells in the colon mucosa of chronic inflammatory bowel disease

[25] quality of life in the late follow-up of ulcerative colitis patients submitted to restorative proctocolectomy with sphincter preservation over ten years ago

[26] exercise in patients with inflammatory bowel diseases: current perspectives

[27] a randomized clinical trial of vitamin d3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis d3

[28] ¿cuándo es demasiado pronto y cuándo demasiado tarde para la cirugía en la enfermedad de crohn? when is it too early or too late for surgery in crohn's disease?

[29] endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study

[30] application of 5-aminosalicylic acid preparations in the treatment of inflammatory bowel diseases

[31] detection of intestinal flora levels as well as cytokine and tlrs molecule expression in patients with ulcerative colitis

[32] drugs as causative agents and therapeutic agents in inflammatory bowel disease

[33] imaging of mucosal inflammation: current technological developments, clinical implications, and future perspectives

[34] anti-inflammatory effects of herbal preparations stw5 and stw5-ii in cytokine-challenged normal human colon cells.

[35] Vitamin D and Ulcerative Colitis: Is There a Relationship with Disease Extent?

[36] Diagnosis of ulcerative colitis and Crohn's disease using transabdominal ultrasonography.

[37] Key Disease-Related Genes and Immune Cell Infiltration Landscape in Inflammatory Bowel Disease: A Bioinformatics Investigation.

[38] The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis

[39] The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis

[40] Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression

[41] Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis

[42] Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.

[43] Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

[44] The combination of indirubin and isatin attenuates dextran sodium sulfate induced ulcerative colitis in mice.

[45] Endoscopy in Postoperative Patients with Crohn's Disease or Ulcerative Colitis. Does It Translate to Better Outcomes?

[46] [Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.]

[47] Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

[48] Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis

[49] Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis

[50] Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.

[51] Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.

[52] Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology.

[53] Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology

[54] Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.

[55] Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?

[56] Functional and quality of life outcomes after ileal pouch-anal anastomosis in short versus long ileal J-pouch configuration in ulcerative colitis patients: a cohort study.

[57] Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats.

[58] Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis

[59] Ulcerative Colitis: A Critical Approach to the Global Research Output Employing Density-equalizing Mapping and Scientometric Methods.

[60] Effects of Aqueous and Methanolic Extracts of Stem Bark of De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats.

[61] Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study.

[62] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

[63] Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1

[64] Chemotaxonomic Analysis of Bacterial Populations Colonizing the Rectal Mucosa in Patients with Ulcerative Colitis

[65] Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

[66] Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

[67] Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis

[68] Vedolizumab for induction and maintenance of remission in ulcerative colitis

[69] Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis

[70] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

[71] Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis

[72] Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

[73] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

[74] Vedolizumab as induction and maintenance therapy for ulcerative colitis

[75] Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

[76] Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life

[77] Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life

[78] Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

[79] nrf-2 expression in ulcerative colitis lesions and its correlation with antioxidant enzyme levels and tissue injury

[80] expressing the differences between crohn disease and ulcerative colitis.

[81] intestinal giardiasis disguised as ulcerative colitis

[82] cause for controversy? infliximab in the treatment of ulcerative colitis: an update

[83] decreased breg/th17 ratio improved the prognosis of patients with ulcerative colitis

[84] topical treatment of ulcerative colitis using enemas containing 5-aminosalicylic acid and beclomethasone dipropionate

[85] myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis

[86] the red hearing: swollen ear in a patient with ulcerative colitis

[87] quality of life in the late follow-up of ulcerative colitis patients submitted to restorative proctocolectomy with sphincter preservation over ten years ago

[88] optimal management of steroid-dependent ulcerative colitis

[89] body composition as an indicator of the nutritional status in children with newly diagnosed ulcerative colitis and crohn’s disease – a prospective study

[90] a randomized clinical trial of vitamin d3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis d3

[91] bullous pemphigoid associated with adalimumab therapy in a patient with ulcerative colitis

[92] the value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: a systematic review and meta-analysis

[93] pas de deux: active ulcerative colitis in an hiv-positive patient

[94] update on the management of ulcerative colitis: treatment and maintenance approaches focused on mmx® mesalamine

[95] protective effect of amphipterygium adstringens extract on dextran sulphate sodium-induced ulcerative colitis in mice

[96] the transient receptor potential vanilloid 1 is associated with active inflammation in ulcerative colitis

[97] dysplasia risk in ileal pouches after reconstructive surgery for ulcerative colitis

[98] fibre utilisation is not defective but colonic epithelial function may be abnormal in quiescent ulcerative colitis

[99] anti-ulcerative colitis activity of calotropis procera linn.

[100] soluble interleukin-2 receptors in ulcerative colitis

[101] quality of life in patients with ileal pouch for ulcerative colitis